KATE MCCABE: Open Payments
NPI 1730735010 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,208 in 99 payments from 15 companies in 2025. Trend: 2023 $2,464 · 2024 $1,747 · 2025 $2,208
Food & beverage: $2,199Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $423 |
| E.R. Squibb & Sons, L.L.C. | 9 | $246 |
| GENZYME CORPORATION | 7 | $233 |
| ABBVIE INC. | 18 | $203 |
| Amgen Inc. | 6 | $187 |
| Galderma Laboratories, L.P. | 16 | $184 |
| Incyte Corporation | 6 | $161 |
| Novartis Pharmaceuticals Corporation | 4 | $130 |
| Organon LLC | 6 | $126 |
| Botanix SB Inc | 5 | $115 |
Products named: TREMFYA, Sotyktu, DUPIXENT, OTEZLA, OPZELURA, NEMLUVIO, SOFDRA, SKYRIZI.
Industry payments across MA — which companies pay providers there.
